Sarah A. Kagan discusses the oral argument in the Myriad Genetics case in IP Law360

April 5, 2011
Dr. Kagan discusses the judges’ reactions to the argument and speculates on a possible outcome in the Myriad Genetics case, in an IP Law360 article titled “Myriad Pushes for Isolated DNA Patents in Fed. Circ.”
Please click here to read the article.

Posted: June 4, 2011

Contact Banner Witcoff Share on LinkedIn View this page as a pdf Share on Twitter Email this page Print this page